The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,012.00
Bid: 2,000.00
Ask: 2,004.00
Change: 0.00 (0.00%)
Spread: 4.00 (0.20%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2,012.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: LSEG says Refinitiv savings bigger, ahead of schedule

Thu, 03rd Mar 2022 08:28

(Alliance News) - London Stock Exchange Group on Thursday said 2021 was a successful year following the acquisition of Refinitiv, leaving the stock exchange operator well positioned as a financial market infrastructure and data business.

For 2021, LSEG generated total income of GBP6.81 billion, up from a pro-forma GBP6.77 billion in 2020. Gross profit rose to GBP6.24 billion from GBP6.16 billion on the same basis. Adjusted pretax profit was GBP2.30 billion, up 27% from GBP1.81 billion. Statutory pretax profit was GBP987m, up from GBP492m.

LSEG declared a final dividend of 70 pence per share, a 27% increase in full year dividend to 95 pence per share, reflecting its strong performance in the year and confidence in outlook.

"The group has delivered a strong financial and operating performance in the first year following the successful completion of the acquisition of Refinitiv, with good revenue growth across all of our businesses. We are making excellent progress on integration and are on track to meet or exceed all the acquisition targets. We have established our position as a leading global market infrastructure and data business, and we carry good momentum into 2022," said Chief Executive Officer David Schwimmer.

LSEG said cost synergies following the Refinitiv acquisition were running ahead of target, with GBP151 million in annual run-rate achieved in 2021. It has identified an additional GBP50 million in cost synergies, raising its five-year target to at least GBP400 million.

LSEG shares were up 9.4% early Thursday.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: called up 0.4% at 7,460.10

----------

Hang Seng: up 0.6% at 22,467.34

Nikkei 225: closed up 0.7% at 26,577.27

S&P/ASX 200: closed up 0.5% at 7,151.40

----------

DJIA: closed up 596.40 points, 1.8%, at 33,891.35

S&P 500: closed up 1.9% at 4,386.54

Nasdaq Composite: closed up 1.6% at 13,752.02

----------

EUR: down at USD1.1098 (USD1.1130)

GBP: up at USD1.3400 (USD1.3363)

USD: firm at JPY115.68 (JPY115.60)

Gold: up at USD1,929.01 per ounce (USD1,923.31)

Oil (Brent): up at USD116.98 a barrel (USD109.94)

(changes since previous London equities close)

----------

ECONOMICS AND GENERAL

----------

Thursday's key economic events still to come

0955 CET Germany services purchasing managers' index

1000 CET EU eurozone services PMI

1100 CET EU producer price index

1100 CET EU unemployment

1300 CET EU ECB meeting accounts

0930 GMT UK services PMI

0830 EST US initial jobless claims

0945 EST US services PMI

1000 EST US ISM report on business services PMI

1000 EST US Fed Chair Powell presents Monetary Policy Report to Congress

1030 EST US EIA weekly natural gas storage report

----------

Russian forces have taken the Black Sea port of Kherson in southern Ukraine, the first major city to fall after a string of setbacks for Moscow. Russia's invasion so far has been astonishingly badly managed, a blundering "disaster, through and through", US defence experts said. It is like Moscow "tripped over the doorframe on the way into the house," one expert said, citing food and fuel shortages, poor intelligence and planning. Ukraine's second city Kharkiv continues to come under heavy Russian shelling, with police and university buildings among the latest struck.

----------

Ratings agencies Fitch and Moody's slashed Russia's sovereign debt to "junk" status, or the category of countries at risk of not being able to repay their debt, a week after Moscow began its assault on Ukraine. Moody's downgraded the rating on Russian long-term debt from Baa3 to B3 subject to a further review over the West's sanctions against Russia, while Fitch lowered its rating from BBB to B, also with a negative outlook. "The multi-notch downgrade of Russia's ratings and maintaining the review for further downgrade were triggered by the severe sanctions that Western countries have imposed on Russia", including on its central bank and some large financial institutions, Moody's said in a statement. The agency also noted a "heightened risk of disruption" to sovereign debt repayment in the face of "severe and coordinated sanctions".

----------

China's service sector slowed at the slowest rate for six months in February, survey data showed, though businesses expressed a stronger optimism for the year ahead. The seasonally adjusted headline business activity index slipped to 50.2 in February from 51.4 in January, signalling only a marginal rise in services activity.

----------

Service providers in Ireland reported the fastest growth in new business in six years, as overall business activity hit a four-month high in February, according to survey results released by IHS Markit. The AIB services business activity index jumped to 61.8 points in February from 56.2 in January, as Covid-19 restrictions were lifted in Ireland. The reading was the highest in four months and well above the long-run average of 55.0 points. The month-on-month acceleration in growth was the sharpest on record, IHS Markit said. The strong services score lifted the AIB Ireland composite purchasing managers' index to 59.1 in February from 56.1 in January, overcoming a decline in the factory sector reading. On Tuesday, IHS Markit had said the manufacturing PMI score was 57.8 points last month, down from 59.4 in January.

----------

BROKER RATING CHANGES

----------

Morgan Stanley cuts Hikma Pharmaceutical to 'equal-weight' ('overweight') - price target 2,300 (2,800) pence

----------

JPMorgan resumes SSP with 'overweight'

----------

COMPANIES - FTSE 100

----------

Housebuilder Taylor Wimpey said it delivered a strong 2021 performance with results in line with its expectations. For 2021, it posted pretax profit GBP679.6 million, up from GBP264.4 million in 2020 on revenue of GBP4.28 billion, up from GBP2.79 billion. 2021 saw a 47% increase in UK completions including joint ventures to 14,087, up from 9,609 in 2020, driven by good build performance and strong demand. Taylor Wimpey declared a final dividend of 4.44 pence for 8.58p total, up from 4.14p in 2020. It also plans GBP150 million share buyback in 2022 to return excess cash. Looking ahead, the company continues to expect to deliver low single-digit year-on-year completions growth in 2022 and to make further progress towards 21% to 22% operating margin target. Its operating margin in 2021 was 19.3%, up from 10.8% in 2020. Taylor Wimpey expects 2022 year-end net cash to be around GBP600 million, depending on the timing of land payments. "With the opportunistic purchase of additional land over the last 18 months, our land pipeline leaves us well placed to accelerate high-quality, profitable volume delivery from 2023, generating additional value and compelling investor returns," said Chief Executive Officer Pete Redfern.

----------

CRH said 2021 was another year of record delivery for the Dublin-based building materials firm, with continued strong cash generation and profit growth. For 2021, CRH posted pretax profit of USD3.34 billion, doubled from USD1.66 billion in 2020 on revenue of USD30.98 billion, up 12% from USD27.59 billion. CRH generated record net cash flows from operating activities of USD4.2 billion in 2021, up from USD3.9 billion in 2020. CRH declared a final dividend of 98.0 US cents per share, resulting in a total dividend of 121.0 cents for the year, up from 115.0 cents in 2020. Looking ahead, CRH expects underlying demand and pricing backdrop to remain favourable in 2022 albeit against an inflationary input cost environment and continued supply chain challenges. Federal funding for infrastructure is underpinned by the passing of the USD1.2 trillion infrastructure package by the US Congress, while the US residential market is expected to continue to grow driven by robust demand, it added.

----------

Coca-Cola HBC revoked its 2022 financial guidance due to the conflict between Russia and Ukraine, two of its key sales territories. The soft drinks bottler noted that 20% of its 2021 volumes and earnings before interest and tax came from the two countries. It temporarily stopped product at its plant in Kyiv on February 24 and evacuated its employees. Coca-Cola HBC said it will use management actions to mitigate the headwinds outside its control and is ready to redeploy marketing spend and capital expenditure to other markets.

----------

Investment manager Schroders said pretax profit jumped by 25% in 2021 to GBP764.1 million from GBP610.5 million in 2020, as net income rose by 18% to GBP2.57 billion from GBP2.18 billion. Schroders hiked its annual dividend by 7.0% to 122.0 pence from 114.0p. "After a period of benign markets there is a risk that the current turbulence will be with us for some while," the company said.

----------

Thursday's shareholder meetings

Chemring Group PLC - AGM

Petro Matad Ltd - AGM

Zytronic PLC - AGM

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
5 Aug 2022 09:43

Barclays downgrades Hikma to 'equalweight' on Generics concerns

(Sharecast News) - Barclays downgraded Hikma Pharmaceuticals on Friday to 'equalweight' from 'overweight' and cut the price target to 1,750p from 2,250p as it said a lack of visibility in the generics division was a real concern.

Read more
5 Aug 2022 08:15

LONDON BRIEFING: London Stock Exchange benefits from market volatility

(Alliance News) - London Stock Exchange Group on Friday said results in the first half of 2022 improved, as this year's interim period had an extra month's worth of contribution from recent acquisition Refinitiv.

Read more
4 Aug 2022 17:05

LONDON MARKET CLOSE: Stocks shrug off BoE's UK recession warning

(Alliance News) - Stocks in London managed to end higher on Thursday despite a bleak warning from the Bank of England regarding to outlook for the UK economy as it jacked up rates by 50 basis points.

Read more
4 Aug 2022 12:09

LONDON MARKET MIDDAY: BoE hikes, expects UK recession in 4th quarter

(Alliance News) - London shares price made some gains on Thursday morning, though these fell well short of the market rise seen on mainland Europe, as traders in London showed signs of trepidation leading up to the Bank of England's interest rate decision.

Read more
4 Aug 2022 10:15

Hikma revenue flat, profits tumble in first half

(Sharecast News) - Hikma shares were tumbling on Thursday morning after the pharmaceuticals company reported flat group revenue in its first half, at $1.21bn, as it slashed its guidance on its lagging generics business.

Read more
4 Aug 2022 09:01

LONDON MARKET OPEN: FTSE 100 underperforms amid pre-BoE trepidation

(Alliance News) - The FTSE 100 underperformed European peers and traded sideways in early dealings on Thursday, with the Bank of England to take centre-stage during a week that so far has been dominated by tensions between the US and China.

Read more
4 Aug 2022 09:00

TOP NEWS: Hikma first half hit by stiff competition for Generics

(Alliance News) - Hikma Pharmaceuticals PLC shares suffered on Thursday, as it lowered annual guidance after a poor performance in its Generics business hit half-year profit.

Read more
4 Aug 2022 07:54

LONDON MARKET PRE-OPEN: Next and Serco up outlook but Hikma lowers

(Alliance News) - Stock prices in London are seen opening ever-so-slightly higher, falling short of the more convincing gains seen in Asia, with investors wary ahead of the latest Bank of England interest rate decision.

Read more
28 Jul 2022 16:06

UK earnings, trading statements calendar - next 7 days

Friday 29 July 
Allianz Technology Trust PLCHalf Year Results
Aston Martin Lagonda Global Holdings PLCHalf Year Results
AstraZeneca PLCHalf Year Results
Babcock International Group PLCFull Year Results
CMC Markets PLCTrading Statement
Croda International PLCHalf Year Results
Glencore PLCTrading Statement
Jupiter Fund Management PLCHalf Year Results
IMI PLCHalf Year Results
Impellam Group PLCHalf Year Results
Industrials REIT LtdTrading Statement
International Consolidated Airlines Group SAHalf Year Results
Intertek Group PLCHalf Year Results
Law Debenture Corp PLCHalf Year Results
Morgan Advanced Materials PLCHalf Year Results
NatWest Group PLCHalf Year Results
Premier Miton Global Renewables Trust PLCHalf Year Results
Rightmove PLCHalf Year Results
Shearwater Group PLCFull Year Results
Standard Chartered PLCHalf Year Results
Walker Crips Group PLCFull Year Results
YouGov PLCTrading Statement
Monday 1 August 
Ascential PLCHalf Year Results
Cranswick PLCQ1 Results
Dialight PLCHalf Year Results
GlobalData PLCHalf Year Results
HSBC Holdings PLCHalf Year Results
Hutchmed (China) LtdHalf Year Results
NAHL Group PLCTrading Statement
Pearson PLCHalf Year Results
Senior PLCHalf Year Results
Seraphine Group PLCFull Year Results
Spectris PLCHalf Year Results
XP Power PLCHalf Year Results
Tuesday 2 August 
BP PLCHalf Year Results
Capital & Counties Properties PLCHalf Year Results
Coats Group PLCHalf Year Results
Devro PLCHalf Year Results
Direct Line Insurance Group PLCHalf Year Results
Domino's Pizza Group PLCHalf Year Results
Fresnillo PLCHalf Year Results
Greggs PLCHalf Year Results
Keller Group PLCHalf Year Results
Man Group PLCHalf Year Results
Rotork PLCHalf Year Results
Sage Group PLCQ3 Results
Staffline Group PLCHalf Year Results
Synthomer PLCHalf Year Results
Travis Perkins PLCHalf Year Results
Virgin Money UK PLCQ3 Results
Wednesday 3 August 
Endeavour Mining PLCHalf Year Results
Ferrexpo PLCHalf Year Results
Hill & Smith Holdings PLCHalf Year Results
Hiscox LtdHalf Year Results
IP Group PLCHalf year Results
LSL Property Services PLCHalf Year Results
Taylor Wimpey PLCHalf Year Results
Thursday 4 August 
Coca-Cola Europacific Partners PLCHalf Year Results
ConvaTec Group PLCHalf Year Results
Evraz PLCHalf Year Results
Glencore PLCHalf Year Results
Gym Group PLCHalf Year Results
Hikma Pharmaceuticals PLCHalf Year Results
Meggitt PLCHalf Year Results
Mondi PLCHalf Year Results
Morgan Sindall Group PLCHalf Year Results
Next PLCTrading Statement
Pantheon International PLCFull Year Results
Revolution Beauty Group PLCFull Year Results
Rolls-Royce Holdings PLCHalf Year Results
ScS Group PLCTrading Statement
Secure Trust Bank PLCHalf Year Results
Serco Group PLCHalf Year Results
Spirent Communications PLCHalf Year Results
Tritax Big Box REIT PLCHalf Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
18 Jul 2022 09:46

LONDON BROKER RATINGS: Trio of downgrades for Fevertree; Admiral cut

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
13 Jul 2022 10:02

LONDON BROKER RATINGS: Jefferies likes Tyman; UBS cuts Beazley

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
25 May 2022 10:05

LONDON BROKER RATINGS: JPMorgan cuts Hikma; Liberum likes Trustpilot

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
25 May 2022 08:28

LONDON BRIEFING: M&S warns on cost hit to profit but is well placed

(Alliance News) - Marks & Spencer on Wednesday reported a swing to profit for the year ended April 2, but the clothing, homewares and food retailer cautioned on profit in the year ahead, amid the war in Ukraine and investment plans.

Read more
24 May 2022 10:29

IN BRIEF: Hikma Pharmaceuticals Chief Executive Siggi Olafsson resigns

Hikma Pharmaceuticals PLC - London-based pharmaceutical company - Says Siggi Olafsson has resigned as chief executive officer and from the board to "pursue other opportunities." Adds he will remain available to the company until he resigns on June 24. Olafsson was appointed as CEO in 2018. Before he joined Hikma, he was president of peer firm Actavis Generics until 2014 from 2012.

Read more
24 May 2022 08:24

LONDON BRIEFING: Barclays launches delayed GBP1 billion share buyback

(Alliance News) - Barclays said it will kick off a GBP1.00 billion share buyback programme on Tuesday. The programme, initially announced in February, had been delayed in March after the bank admitted it sold more financial products to investors than it was allowed to.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.